Samantha Shenoy, NP, MSN, provides nursing guidance on teclistamab/subcutaneous daratumumab’s second-line approval in multiple myeloma. On March 5, the FDA approved the combination of teclistamab ...
Strings’ Agentic AI predicts clinical intent to accelerate workflow, minimize manual tasks, and lower healthcare costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results